Insights into atrial fibrillation.

Area of Science:

• Cardiology
• Internal Medicine
• Pharmacology

Background:

• Atrial fibrillation (AF) is the most common heart rhythm disorder, increasing morbidity and mortality.
• Key risk factors include advanced age, hypertension, diabetes, heart failure, and rheumatic heart disease.
• AF is classified into paroxysmal, persistent, long-standing persistent, and permanent types, influencing treatment strategies.

Purpose of the Study:

• To outline current therapeutic approaches for atrial fibrillation.
• To discuss the role of rhythm and rate control strategies.
• To review oral anticoagulation therapies for stroke prevention in AF.

Main Methods:

• Review of AF classification and management guidelines.
• Analysis of treatment options including cardioversion, anti-arrhythmic drugs, and ablation.
• Evaluation of oral anticoagulants, including vitamin K antagonists and novel oral anticoagulants (NOACs).

Main Results:

• Treatment strategies vary based on AF classification (paroxysmal, persistent, permanent).
• Rhythm control is attempted for paroxysmal and persistent AF, while rate control is primary for permanent AF.
• Novel oral anticoagulants demonstrate efficacy and safety for stroke prevention, offering convenience over warfarin but with challenges like cost and lack of specific antidotes.

Conclusions:

• AF management requires tailored strategies based on type, patient factors, and symptoms.
• Oral anticoagulation is essential for stroke risk reduction in AF.
• NOACs represent a significant advancement in AF anticoagulation, though cost and antidote availability require consideration.